Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.
Curr Opin Biotechnol. 2011 Dec;22(6):901-8. doi: 10.1016/j.copbio.2011.04.020. Epub 2011 May 16.
Several nanoparticle platforms are currently being developed for applications in medicine, including both synthetic materials and naturally occurring bionanomaterials such as viral nanoparticles (VNPs) and their genome-free counterparts, virus-like particles (VLPs). A broad range of genetic and chemical engineering methods have been established that allow VNP/VLP formulations to carry large payloads of imaging reagents or drugs. Furthermore, targeted VNPs and VLPs can be generated by including peptide ligands on the particle surface. In this article, we highlight state-of-the-art virus engineering principles and discuss recent advances that bring potential biomedical applications a step closer. Viral nanotechnology has now come of age and it will not be long before these formulations assume a prominent role in the clinic.
目前正在开发几种纳米颗粒平台,用于医学应用,包括合成材料和天然存在的生物纳米材料,如病毒纳米颗粒(VNPs)及其无基因组对应物,类病毒颗粒(VLPs)。已经建立了广泛的遗传和化学工程方法,允许 VNP/VLP 制剂携带大量成像试剂或药物的有效载荷。此外,通过在颗粒表面包含肽配体,可以生成靶向 VNPs 和 VLPs。在本文中,我们强调了最先进的病毒工程原理,并讨论了使潜在的生物医学应用更接近现实的最新进展。病毒纳米技术已经成熟,这些制剂在临床中发挥重要作用指日可待。